alpha-Galactosidase, antagonists & inhibitors

DBCAT001655Pharmacologic class

A DrugBank category of 5 drugs. 5 of them are approved.

What you can answer from here — as of August 12, 2019

5DrugsEach linked to its full drug card

Listed above

26Drug targetsEvery drug–target pair in the class, with bond type

1,316Marketed productsAcross the regions we cover, with dosage forms and routes

14Routes of administrationHow the drugs in this class are given

Which targets do alpha-Galactosidase, antagonists & inhibitors share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.